📖

ai-tool-alibaba-tongyi-qianwen-bio

active
wiki page Created: 2026-04-11T21:17:13 By: crosslink-v2 Quality: 50% ✓ SciDEX ID: wiki-ai-tool-alibaba-tongyi-qianwen-bio
🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

📊 Evidence Profile
Evidence Balance
+0%
Certainty
100%
Debates
0
Incoming
241
Outgoing
271
0 supporting 0 contradicting 0 neutral
View full evidence profile →
Linked Artifacts (278)
related🧪Complement-Mediated Synaptic Pruning Dysregulation70%
related🧪KDM6A-Mediated H3K27me3 Rejuvenation70%
related🧪Chaperone-Mediated APOE4 Refolding Enhancement70%
related🧫CBS vs PSP Phenotype Determinants — Single-Nucleus Multi-Omi70%
related🧪Mitochondrial Calcium Buffering Enhancement via MCU Modulati70%
related🧫Experiment Scoring Methodology70%
related🧪Selective HDAC3 Inhibition with Cognitive Enhancement70%
related🧪FOXO3-Longevity Pathway Epigenetic Reprogramming70%
related🧪Bacterial Enzyme-Mediated Dopamine Precursor Synthesis70%
related🧪Cryptic Exon Silencing Restoration70%
related🧫s:** - Biochemical binding assays measuring PROTAC selectivi70%
related🧪Ephrin-B2/EphB4 Axis Manipulation70%
related🧪Multi-Modal CRISPR Platform for Simultaneous Editing and Mon70%
related🧪Orexin-Microglia Modulation Therapy70%
related🧪Glymphatic System-Enhanced Antibody Clearance Reversal70%
related🧪Serine/Arginine-Rich Protein Kinase Modulation70%
related🧫Mutant Huntingtin (mHTT) Clearance Mechanisms — Therapeutic 70%
related🧪Proteostasis Enhancement via APOE Chaperone Targeting70%
related🧪Circadian-Synchronized Proteostasis Enhancement70%
related🧪Designer TRAK1-KIF5 fusion proteins accelerate therapeutic m70%
related🧪Glycine-Rich Domain Competitive Inhibition70%
related🧪Brain Insulin Resistance with Glucose Transporter Dysfunctio70%
related🧫Epigenetic Clocks in Neurodegeneration — Causal Drivers or P70%
related🧪Digital Twin-Guided Metabolic Reprogramming70%
related🧫Tau PET Pattern as Therapeutic Response Predictor in 4R-Tauo70%
related🧪Astrocyte-Mediated Neuronal Epigenetic Rescue70%
related🧪Osmotic Gradient Restoration via Selective AQP1 Enhancement 70%
related🧪Enhancing Vagal Cholinergic Signaling to Restore Gut-Brain A70%
related🧪Astroglial Gap Junction Coordination via Connexin-43 Phospho70%
related🧫Protein Aggregation Kinetic Validation Results70%
related🧪Lysosomal Calcium Channel Modulation Therapy70%
related🧪Mitochondrial RNA Granule Rescue Pathway70%
related🧪APOE-Dependent Autophagy Restoration70%
related🧪PINK1/Parkin-Independent Mitophagy Bypass for Enhanced Donor70%
related🧪Aquaporin-4 Polarization Rescue70%
related🧪Metabolic Reprogramming via Microglial Glycolysis Inhibition70%
related🧪Senescence-Induced Lipid Peroxidation Spreading70%
related🧪Astrocytic Connexin-43 Upregulation Enhances Neuroprotective70%
related🧪Phase-Separated Organelle Targeting70%
related🔬Senescent cell clearance as neurodegeneration therapy70%
related🧫Levodopa Response Determinants in PSP — Biomarker-Guided Pre70%
related🧫Iron Dyshomeostasis in MSA Pathogenesis Experiment70%
related🧫s:** - Test tau spreading in AQP4 knockout vs wild-type mice70%
related🧫s:** - Dose-response studies showing therapeutic window with70%
related🧫Selective Vulnerability of Dopaminergic Neurons — Mechanism 70%
related🧪Circadian-Synchronized LRP1 Pathway Activation70%
related🧪R-Loop Resolution Enhancement Therapy70%
related🧪Microglial Purinergic Reprogramming70%
related🧪Senescent Microglia Resolution via Maresins-Senolytics Combi70%
related🧪RNA Granule Nucleation Site Modulation70%
related🧫Genetic Risk Modifiers in DLB Phenotype70%
related🧪Complement C1q Mimetic Decoy Therapy70%
related🧪Axonal RNA Transport Reconstitution70%
related🧪Enteric Nervous System Prion-Like Propagation Blockade70%
related🧪Fractalkine Axis Amplification via CX3CR1 Positive Allosteri70%
related🧪Senescence-Associated Myelin Lipid Remodeling70%
related🧪Context-Dependent CRISPR Activation in Specific Neuronal Sub70%
related🧪Glycosaminoglycan Template Disruption Approach70%
related🧪CYP46A1 Overexpression Gene Therapy70%
related🧪Membrane Cholesterol Gradient Modulators70%
related🧪Netrin-1 Gradient Restoration70%
related🧫Anti-Tau Antibody vs ASO/Gene Therapy — Comparative Efficacy70%
related🧪Near-infrared light therapy stimulates COX4-dependent mitoch70%
related🧪Microbiome-Derived Tryptophan Metabolite Neuroprotection70%
related🧪Blocking AGE-RAGE Signaling in Enteric Glia to Prevent Neuro70%
related🧪Noradrenergic-Tau Propagation Blockade70%
related🧪Chromatin Accessibility Restoration via BRD4 Modulation70%
related🧫Proposed experiment from debate on Epigenetic clocks and bio70%
related🧪PARP1 Inhibition Therapy70%
related🧪SASP-Mediated Cholinergic Synapse Disruption70%
related🧫Spinocerebellar Ataxia (SCA) Disease-Modifying Therapy Devel70%
related🧫GLP-1 Agonist Responder Prediction Study — Precision Medicin70%
related🧪Gap Junction Hemichannel Modulation for Controlled Mitochond70%
related🧪Optogenetic Microglial Deactivation via Engineered Inhibitor70%
related🧫Prion Strain Diversity and Selective Vulnerability in CJD70%
related🧪APOE4 Allosteric Rescue via Small Molecule Chaperones70%
related🧪Mechanosensitive Ion Channel Reprogramming70%
related🧫Proposed experiment from debate on Perivascular spaces and g70%
related🧫s:** - Compare tau strain spreading in EXT1/EXT2 conditional70%
related🧪Circadian Clock-Autophagy Synchronization70%
related🧪Cross-Seeding Prevention Strategy70%
related🧫Levodopa-Induced Dyskinesias Mechanism — Experiment Design70%
related🧪Autophagosome Maturation Checkpoint Control70%
related🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer70%
related🧪Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th70%
related🧪Circadian-Gated Maresin Biosynthesis Amplification70%
related🧪Programmable Neuronal Circuit Repair via Epigenetic CRISPR70%
related🧪SASP-Mediated Complement Cascade Amplification70%
related🧪TREM2-Mediated Selective Aggregate Clearance Pathway70%
related🧪Complement C1q Subtype Switching70%
related🧪Stress Granule Phase Separation Modulators70%
related🧪Pericyte Contractility Reset via Selective PDGFR-β Agonism70%
related🧪Oligodendrocyte Protectin D1 Mimetic for Myelin Resolution70%
related🧪Synthetic Biology BBB Endothelial Cell Reprogramming70%
related🧫Frontal and Temporal Lobe Selective Vulnerability in FTD — M70%
related🧪Synthetic Biology Approach: Designer Mitochondrial Export Sy70%
related🧫Tau Spreading Network Mapping via Spatial Transcriptomics in70%
related🧪Circadian Glymphatic Entrainment via Targeted Orexin Recepto70%
related🧪Retinal Vascular Microcirculation Rescue70%
related🧪GAP43-mediated tunneling nanotube stabilization enhances neu70%
related🧫Sleep and Circadian Dysfunction as Driver of Neurodegenerati70%
related🧪Epigenetic Memory Reprogramming for Alzheimer's Disease70%
related🧪Prohibitin-2 Mitochondrial Cross-Seeding Hub Disruption70%
related🧪Epigenetic Memory Erasure via TET2 Activation70%
related🧪APOE4-Selective Lipid Nanoemulsion Therapy70%
related🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides70%
related🧪Lysosomal Enzyme Trafficking Correction70%
related🧪Sleep Spindle-Synaptic Plasticity Enhancement70%
related🧪Microbial Inflammasome Priming Prevention70%
related🧪Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modu70%
related🧫s:** - Compare uptake with/without magnetic particles using 70%
related🧪AMPK hypersensitivity in astrocytes creates enhanced mitocho70%
related🧪Lysosomal Positioning Dynamics Modulation70%
related🧪Miro1-Mediated Mitochondrial Trafficking Enhancement Therapy70%
related🧪HSP70 Co-chaperone DNAJB6 Universal Cross-Seeding Inhibitor70%
related🧪Age-Dependent Complement C4b Upregulation Drives Synaptic Vu70%
related🧫Selective Neuronal Vulnerability to Aging — Mapping Why Spec70%
related🧪Pharmacological Enhancement of APOE4 Glycosylation70%
related🧪Flotillin-1 Stabilization Compounds70%
related🧫Blood-Brain Barrier Aging and Neurodegeneration — From Leaka70%
related🧪Optogenetic Control of Mitochondrial Transfer Networks70%
related🧪Arginine Methylation Enhancement Therapy70%
related🧪Mitochondrial-Nuclear Epigenetic Cross-Talk Restoration70%
related🧪Glial Glycocalyx Remodeling Therapy70%
related🧪Vagal Afferent Microbial Signal Modulation70%
related🧪Senescent Cell Mitochondrial DNA Release70%
related🧪DNMT1-Targeting Antisense Oligonucleotide Reset70%
related🧪SASP-Driven Aquaporin-4 Dysregulation70%
related🧪Nucleolar Stress Response Normalization70%
related🧪Reelin-Mediated Cytoskeletal Stabilization Protocol70%
related🧫Wilson Disease Neurodegeneration: Mechanism and Therapeutic 70%
related🧫Proposed experiment from debate on Mitochondrial transfer be70%
related🧪Microglia-Derived Extracellular Vesicle Engineering for Targ70%
related🧪Grid Cell-Specific Metabolic Reprogramming via IDH2 Enhancem70%
related🧪TREM2-Dependent Microglial Senescence Transition70%
related🧪The Mitochondrial-Lysosomal Metabolic Coupling Dysfunction70%
related🧫Tau Co-Pathology in DLB Clinical Heterogeneity70%
related🧪Correcting Gut Microbial Dopamine Imbalance to Support Syste70%
related🧪Piezoelectric Nanochannel BBB Disruption70%
related🧪Targeted Butyrate Supplementation for Microglial Phenotype M70%
related🧪TREM2 Conformational Stabilizers for Synaptic Discrimination70%
related🧪HDAC3-Selective Inhibition for Clock Reset70%
related🧪Heat Shock Protein 70 Disaggregase Amplification70%
related🧪TFEB-PGC1α Mitochondrial-Lysosomal Decoupling70%
related🧪Lysosomal Membrane Repair Enhancement70%
related🧪Gut Barrier Permeability-α-Synuclein Axis Modulation70%
related🧪Purinergic Signaling Polarization Control70%
related🧪Extracellular Matrix Stiffness Modulation70%
related🧪CX43 hemichannel engineering enables size-selective mitochon70%
related🧪Matrix Stiffness Normalization via Targeted Lysyl Oxidase In70%
related🧪APOE-TREM2 Interaction Modulation70%
related🧪Biorhythmic Interference via Controlled Sleep Oscillations70%
related🧪Synaptic Phosphatidylserine Masking via Annexin A1 Mimetics70%
related🧪RNA-Binding Competition Therapy for TDP-43 Cross-Seeding70%
related🧪Synthetic Biology Rewiring via Orthogonal Receptors70%
related🧪Multi-Modal Stress Response Harmonization70%
related🧪Sphingolipid Metabolism Reprogramming70%
related🧪Mitochondrial SPM Synthesis Platform Engineering70%
related🧪Lipid Droplet Dynamics as Phenotype Switches70%
related🧪Low Complexity Domain Cross-Linking Inhibition70%
related🧪Cholesterol-CRISPR Convergence Therapy for Neurodegeneration70%
related🧪Targeted APOE4-to-APOE3 Base Editing Therapy70%
related🧫Presymptomatic GRN Carrier Intervention Timing — Biomarker-G70%
related🧫Tau Pathology Initiation Zone Identification70%
related🧪HCN1-Mediated Resonance Frequency Stabilization Therapy70%
related🧪Aquaporin-4 Polarization Enhancement via TREK-1 Channel Modu70%
related🧪Quantum Coherence Disruption in Cellular Communication70%
related🧫Experiment Index70%
related🧪Smartphone-Detected Motor Variability Correction70%
related🧪Perforant Path Presynaptic Terminal Protection Strategy70%
related🧪Astrocytic Lactate Shuttle Enhancement for Grid Cell Bioener70%
related🧪Ganglioside Rebalancing Therapy70%
related🧫NPH Glymphatic System Interaction Experiment70%
related🧪Ocular Immune Privilege Extension70%
related🧪APOE Isoform Conversion Therapy70%
related🧪Sphingomyelin Synthase Activators for Raft Remodeling70%
related🧫Proposed experiment from debate on Perivascular spaces and g70%
related🧪Mitochondrial-Lysosomal Contact Site Engineering70%
related🧫s:** - Temporal analysis showing mitochondrial defects prece70%
related🧪APOE-Mediated Synaptic Lipid Raft Stabilization70%
related🧪Palmitoylation-Targeted BACE1 Trafficking Disruptors70%
related🧫Proposed experiment from debate on Epigenetic clocks and bio70%
related🧪RAB27A-dependent extracellular vesicle engineering for mitoc70%
related🧪TET2-Mediated Demethylation Rejuvenation Therapy70%
related🧪Competitive APOE4 Domain Stabilization Peptides70%
related🧪TFAM overexpression creates mitochondrial donor-recipient gr70%
related🧫Proposed experiment from debate on Senolytics targeting p16/70%
related🧪The Glial Ketone Metabolic Shunt Hypothesis70%
related🧪Partial Neuronal Reprogramming via Modified Yamanaka Cocktai70%
related🧪Blood-Brain Barrier SPM Shuttle System70%
related🧪Vocal Cord Neuroplasticity Stimulation70%
related🧫Circadian-Vascular-Metabolic Syndrome (CVMS) Intervention Tr70%
related🧪Trinucleotide Repeat Sequestration via CRISPR-Guided RNA Tar70%
related🧪Senescence-Activated NAD+ Depletion Rescue70%
related🧫Biomechanical Impact Profiles and Chronic Traumatic Encephal70%
related🧫Proposed experiment from debate on Astrocytes adopt A1 (neur70%
related🧪Mitochondrial Transfer Pathway Enhancement70%
related🧪Oligodendrocyte White Matter Vulnerability70%
related🧫Proposed experiment from debate on Microglia activate astroc70%
related🧪Microbial Metabolite-Mediated α-Synuclein Disaggregation70%
related🧫Proposed experiment from debate on Astrocytes adopt A1 (neur70%
related🧪Selective TLR4 Modulation to Prevent Gut-Derived Neuroinflam70%
related🧪Magnetosonic-Triggered Transferrin Receptor Clustering70%
related🧪SIRT6-NAD+ Axis Enhancement Therapy70%
related🧫s:** - Test MCU overexpression specifically in layer II neur70%
related🧪Metabolic Circuit Breaker via Lipid Droplet Modulation70%
related🧪Transglutaminase-2 Cross-Linking Inhibition Strategy70%
related🧪Temporal TET2-Mediated Hydroxymethylation Cycling70%
related🧫DLB Cognitive Fluctuation Mechanism Experiment70%
related🧪Tau-Independent Microtubule Stabilization via MAP6 Enhanceme70%
related🧪Circadian Glymphatic Rescue Therapy (Melatonin-focused)70%
related🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction70%
related🧫TMEM106B Haplotype as Genetic Modifier in FTD — Mechanism an70%
related🧪Selective Acid Sphingomyelinase Modulation Therapy70%
related🧫Proposed experiment from debate on Mitochondrial transfer be70%
related🧪Transcriptional Autophagy-Lysosome Coupling70%
related🧪Targeting Bacterial Curli Fibrils to Prevent α-Synuclein Cro70%
related🧪Microglial Efferocytosis Enhancement via GPR32 Superagonists70%
related🧪Hypocretin-Neurogenesis Coupling Therapy70%
related🧫Epigenetic Dysregulation in Huntington's Disease — Ther70%
related🧪Liquid-Liquid Phase Separation Modifier Therapy70%
related🧪Circadian Rhythm Entrainment of Reactive Astrocytes70%
related🧪Endothelial Glycocalyx Regeneration via Syndecan-1 Upregulat70%
related🧫Tau Propagation Causality Test — Does Tau Spread Drive Neuro70%
related🧪Metabolic Reprogramming via Coordinated Multi-Gene CRISPR Ci70%
related🧪Restoring Neuroprotective Tryptophan Metabolism via Targeted70%
related🧫Proposed experiment from debate on TDP-43 undergoes liquid-l70%
related🧪Nutrient-Sensing Epigenetic Circuit Reactivation70%
related🧫Proposed experiment from debate on TDP-43 undergoes liquid-l70%
related🧫Biomechanical Impact Profiles and Chronic Traumatic Encephal70%
related🧪Metabolic Switch Targeting for A1→A2 Repolarization70%
related🧪Purinergic P2Y12 Inverse Agonist Therapy70%
related🧫DLB Treatment Response Biomarkers — Predicting Cholinesteras70%
related🧪Temporal Decoupling via Circadian Clock Reset70%
related🧪Adenosine-Astrocyte Metabolic Reset70%
related🔬Investigate how lipid raft composition (cholesterol metaboli68%
related🔬Senolytics targeting p16/p21+ senescent astrocytes and micro67%
related🔬RNA binding protein dysregulation across ALS FTD AD66%
related🔬Sleep disruption as cause and consequence of neurodegenerati64%
related🔬Anti-amyloid antibodies (lecanemab, donanemab) have ~0.1% br64%
related🔬Senescent cell clearance as neurodegeneration therapy63%
related🔬Mitochondrial transfer between astrocytes and neurons62%
related🔬Investigate how lipid raft composition (cholesterol metaboli61%
related🔬Senolytics targeting p16/p21+ senescent astrocytes and micro60%
related🔬APOE4 differs from APOE3 by C112R causing domain interaction60%
related🔬What is the therapeutic window between insufficient and toxi59%
related🔬PSP and CBD both involve 4R-tau but produce distinct neuropa58%
related🔬Sleep disruption as cause and consequence of neurodegenerati58%
related🔬Anti-amyloid antibodies (lecanemab, donanemab) have ~0.1% br58%
related🔬SPMs (resolvins, protectins, maresins) from omega-3s may pro57%
related🔬TDP-43 undergoes liquid-liquid phase separation that becomes57%
related🔬RNA binding protein dysregulation across ALS FTD and AD56%
related🔬Mitochondrial transfer between astrocytes and neurons56%
related🔬Microglia activate astrocytes via IL-1alpha/TNF/C1q, and rea56%
related🔬Analysis question not specified55%
related🔬Multiple NDDs converge on autophagy-lysosome dysfunction. Ar55%
related🔬Analysis question not specified55%
related🔬APOE4 differs from APOE3 by C112R causing domain interaction54%
related🔬Synaptic pruning by microglia in early AD54%
related🔬Why do entorhinal cortex layer II stellate neurons die first54%
related🔬CRISPR-based therapeutic approaches for neurodegenerative di53%
related🔬Epigenetic reprogramming in aging neurons52%
related🔬Astrocytes adopt A1 (neurotoxic) and A2 (neuroprotective) ph51%
related🔬Can speech, gait, retinal imaging, sleep, and smartphone dat50%
related🔬Neuroinflammation and microglial priming in early Alzheimer&50%
related🔬Cell type vulnerability in Alzheimer's Disease (SEA-AD 50%
related🔬Does TFEB dysfunction cause neurodegeneration or represent a50%
related🔬How does metabolic reprogramming (glucose metabolism shifts,50%
related🔬Gene expression changes in aging mouse brain predicting neur50%
related🔬Which cell types show the most significant expression change50%
related🔬Perivascular spaces and glymphatic clearance failure in AD49%
related🔬SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas40%
related🔬Circuit-level neural dynamics in neurodegeneration — Analysi40%
related🔬Analysis question not specified40%
related🔬Tau propagation mechanisms and therapeutic interception poin40%
related🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc40%
related🔬What are the mechanisms underlying what are the mechanisms b38%
related🔬Epigenetic clocks and biological aging in neurodegeneration36%

💬 Discussion